A Simplified Method for the Isolation of Extracellular Vesicles from Probiotic Bacteria and Their Characterization
Open Access
- 26 January 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (3) , 1058
Abstract
Probiotic bacteria are normal inhabitants of a healthy human gut, conferring multiple beneficial effects on the gut and beyond. Under various disease states, the abundance and diversity of beneficial bacteria are significantly decreased, a process called dysbiosis. Among the intra- and extracellular components of probiotics, the extracellular vesicles (EVs) secreted by them have recently garnered significant attention as potential mediators of probiotics’ effects on host health. Further, these nanosized particles that encapsulate a wide range of bioactive molecules (proteins, lipids, RNA, and DNA) are standing out as key factors that could mediate gut microbiota–host communication and confer ameliorating effects in experimental inflammatory, metabolic, and cardiovascular disease models. However, a standard protocol of EV isolation from probiotic bacteria, not varying from lab to lab, must be established to achieve consistency in the experimental results in these pre-clinical models. Our current study compared two commonly used methods for EV isolation from biological samples, ultracentrifugation and precipitation, to develop a standard protocol for isolating EVs from the probiotics Lactobacillus acidophilus (LA), a Gram-positive bacterium, and Escherichia coli Nissle (EcN), a Gram-negative bacterium. The ultracentrifugation method gave ~1.5-fold higher EV yield for both LA and EcN compared to the precipitation method. Further, EcN released a higher level of EVs compared to LA. EVs were quantified and characterized by nanoparticle-tracking analysis (NTA) and by measuring the specific surface biomarkers using Western blot. Here, we describe our standardized step-by-step protocol for isolating EVs from probiotic bacteria and their characterization.Keywords
Funding Information
- National Institute of Allergy and Infectious Disease (AI130790-03, P20 GM 121299-04, 1R01NS102720, P20GM103434, 2U54GM104942)
- National Institute of General Medical Sciences (AI130790-03, P20 GM 121299-04, 1R01NS102720, P20GM103434, 2U54GM104942)
- National Institute of Neurological Disorders and Stroke (AI130790-03, P20 GM 121299-04, 1R01NS102720, P20GM103434, 2U54GM104942)
- Pilot grants from WV-INBRE (AI130790-03, P20 GM 121299-04, 1R01NS102720, P20GM103434, 2U54GM104942)
- West Virginia Clinical and Translational Science Institute (WV-CTSI) (AI130790-03, P20 GM 121299-04, 1R01NS102720, P20GM103434, 2U54GM104942)
This publication has 33 references indexed in Scilit:
- Harnessing Lactobacillus reuteri ‐Derived Extracellular Vesicles for Multifaceted Cancer TreatmentSmall, 2024
- Next-generation probiotics: the upcoming biotherapeuticsMolecular Biology Reports, 2024
- Comparison of the efficiency of ultrafiltration, precipitation, and ultracentrifugation methods for exosome isolationBiochemistry and Biophysics Reports, 2024
- Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategiesMaterials Today Bio, 2023
- Production and purification of bacterial membrane vesicles for biotechnology applications: Challenges and opportunitiesElectrophoresis, 2022
- Isolation and characterization of extracellular vesicles and future directions in diagnosis and therapyWIREs Nanomedicine and Nanobiotechnology, 2022
- Bacterial extracellular vesicles as bioactive nanocarriers for drug delivery: Advances and perspectivesBioactive Materials, 2021
- Bacterial extracellular vesicles: Understanding biology promotes applications as nanopharmaceuticalsAdvanced Drug Delivery Reviews, 2021
- Role of bacterial infections in extracellular vesicles release and impact on immune responseBiomedical Journal, 2021
- Exosome Isolation by Ultracentrifugation and Precipitation and Techniques for Downstream AnalysesCurrent Protocols in Cell Biology, 2020